It is worth mentioning that the blood levels of MEG3 are higher in COPD patients but lower in non-small-cell lung cancer patients.[26,27] Thus, the role of MEG3 in COPD with lung cancer requires further research and validation. The gene discussed is MEG3; the disease is non-small cell lung carcinoma.